Clinical Trials Browser

OTHER × Breast Neoplasms × Tablets × Clear all

NCT04055493 2026-05-11

ADAPTcycle

Phase 3 Active not recruiting

Breast Neoplasms

NCT07292207 2025-12-18

ARCHE

Phase 2 Not yet recruiting

Breast Neoplasms

NCT04456920 2025-12-02

BIO-PSY

Phase NA Completed

193 enrolled 19 charts

Breast Neoplasms

NCT05559164 2025-11-14

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Phase 2 Recruiting

Breast Neoplasms, Cardiotoxicity

NCT06150898 2025-06-13

KePreSt

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

NCT06774885 2025-01-14

ROLE OF FOLIC ACID IN THE MANAGEMENT OF ADJUVANT ENDOCRINE THERAPY-INDUCED HOT FLASHES IN BREAST CANCER PATIENTS

Phase 3 Not yet recruiting

Breast Neoplasms, Hot Flashes

NCT05163106 2024-08-02

NEOLETRIB

Phase 2 Completed

Breast Neoplasms

NCT06229067 2024-01-29

Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer

Phase 2 Not yet recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05840068 2023-05-03

IGF Level in Breast Cancer Patients Treated With Metformin

Phase 4 Completed

Breast Neoplasms

NCT02897050 2022-04-20

Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer

Phase 2 Suspended

Breast Neoplasms

NCT04389073 2022-02-25

Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine

Phase 2 Unknown

Breast Neoplasms

NCT04601116 2021-01-14

The MASTER Study (MAmmary Cancer STatin ER Positive Study)

Phase 3 Recruiting

Breast Neoplasms

NCT04434404 2020-06-16

Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy

Phase 4 Completed

Breast Neoplasms, Cardiotoxicity

NCT00723398 2018-11-01

Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention

Phase NA Completed

266 enrolled 20 charts

Breast Neoplasms